Glucagon-like peptide-1 (GLP-1) analogs have emerged as a compelling therapeutic strategy for managing metabolic disorders. These naturally occurring substances are secreted by the gut in response to meal intake, https://thefairlist.com/story10624793/unveiling-the-therapeutic-potential-of-glp-1-peptides